Detailed View
KNSA - Kiniksa Pharmaceuticals Interna
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
5,950,891,520
Adj EBIT (TTM)
124,517,000
Enterprise Value
5,424,963,520
Last Price
76.27
Earnings Yield
2.30%
Return on Capital
17.53%
Capital
710,113,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 243,600,000 | 27,194,000 |
| 2026-03-31 | 10-Q | 2026 | 214,266,000 | 29,267,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 202,127,000 | 19,768,000 |
| 2025-09-30 | 10-Q | 2025 | 180,855,000 | 24,021,000 |
| 2025-06-30 | 10-Q | 2025 | 156,797,000 | 20,160,000 |
| 2025-03-31 | 10-Q | 2025 | 137,785,000 | 13,272,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 122,536,000 | -19,299,000 |
| 2024-09-30 | 10-Q | 2024 | 112,214,000 | -9,658,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.